Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.
Articles > Abstract · 2020
Authors: Gul Basaran, Umut Demirci, Fatih Yildiz, Irfan Cicin, Burak Yasin Aktas, Banu Ozturk, Sema Sezgin Goksu, Hasan Senol Coskun, Basak Oyan, Ozlem Sonmez, Yesim Eralp, Erhan GÖKMEN, Seyda Gunduz, Taner Korkmaz, Mehmet Ali Nahit Sendur, Serkan Keskin
JOURNAL OF CLINICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, 2020, vol 38